{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:38:26Z","timestamp":1793140706167,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018854","name":"Sirtex Medical Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018854","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jvir.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jvir.2024.07.010","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T05:55:48Z","timestamp":1721627748000},"page":"1793-1805.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Immune Modulation in Untreated, Contralateral Hepatic Metastases after Yttrium-90 Radioembolization of Microsatellite Stable Colorectal Cancer"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1909-3713","authenticated-orcid":false,"given":"Elif","family":"\u00d6cal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9710-1662","authenticated-orcid":false,"given":"Marianna","family":"Alunni-Fabbroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignazio","family":"Piseddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Thaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias J.","family":"Zacherl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7878-4245","authenticated-orcid":false,"given":"Lukas","family":"Salvermoser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1810-3529","authenticated-orcid":false,"given":"Matthias M.R.","family":"Stechele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu Forn\u00e9s","family":"Burnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidrun","family":"Hirner-Eppeneder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6833-9738","authenticated-orcid":false,"given":"Melanie A.","family":"Kimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Rudelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2481-5410","authenticated-orcid":false,"given":"Max","family":"Seidensticker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7228-6963","authenticated-orcid":false,"given":"Moritz","family":"Wildgruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2940-9822","authenticated-orcid":false,"given":"S. Nahum","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Ricke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2024.07.010_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jvir.2024.07.010_bib2","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in microsatellite-instability-high advanced colorectal cancer","volume":"383","author":"Andr\u00e9","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvir.2024.07.010_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4161\/cbt.3.1.590","article-title":"Evaluation of microsatellite instability, hMLH1 expression and hMLH1 promoter hypermethylation in defining the MSI phenotype of colorectal cancer","volume":"3","author":"Arnold","year":"2004","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.jvir.2024.07.010_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Cervantes","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jvir.2024.07.010_bib5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/gutjnl-2017-315485","article-title":"Immune activation underlies a sustained clinical response to yttrium-90 radioembolisation in hepatocellular carcinoma","volume":"68","author":"Chew","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jvir.2024.07.010_bib6","doi-asserted-by":"crossref","first-page":"382-e776","DOI":"10.1634\/theoncologist.2019-0924","article-title":"A\u00a0pilot feasibility study of yttrium-90 liver radioembolization followed by durvalumab and tremelimumab in patients with microsatellite stable colorectal cancer liver metastases","volume":"25","author":"Wang","year":"2020","journal-title":"Oncologist"},{"key":"10.1016\/j.jvir.2024.07.010_bib7","first-page":"216","article-title":"Combining selective internal radiation therapy with immunotherapy in treating hepatocellular carcinoma and hepatic colorectal metastases: a systematic review","volume":"38","author":"Ramdhani","year":"2023","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.jvir.2024.07.010_bib8","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s00270-020-02612-4","article-title":"Intra-hepatic abscopal effect following radioembolization of hepatic metastases","volume":"43","author":"Powerski","year":"2020","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2024.07.010_bib9","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00270-011-0295-7","article-title":"Hepatic toxicity after radioembolization of the liver using 90 Y-microspheres: sequential lobar versus whole liver approach","volume":"35","author":"Seidensticker","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2024.07.010_bib10","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/hep.29207","article-title":"Prevention and treatment of complications of selective internal radiation therapy: expert guidance and systematic review","volume":"66","author":"Sangro","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2024.07.010_bib11","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1200\/JCO.2015.66.1181","article-title":"SIRFLOX: randomized phase III trial comparing first-line mFOLFOX6 (plus or minus bevacizumab) versus mFOLFOX6 (plus or minus bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer","volume":"34","author":"van Hazel","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jvir.2024.07.010_bib12","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejca.2021.01.025","article-title":"Gender-dependent survival benefit from first-line irinotecan in metastatic colorectal cancer. Subgroup analysis of a phase III trial (XELAVIRI-study, AIO-KRK-0110)","volume":"147","author":"Heinrich","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jvir.2024.07.010_bib13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jss.2014.06.001","article-title":"The prognostic value of liver tumor T cell infiltrates","volume":"191","author":"Khan","year":"2014","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.jvir.2024.07.010_bib14","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1245\/s10434-012-2668-9","article-title":"Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases","volume":"20","author":"Katz","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jvir.2024.07.010_bib15","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00262-009-0781-9","article-title":"Intratumoral CD8(+) T\/FOXP3 (+) cell ratio is a predictive marker for survival in patients with colorectal cancer","volume":"59","author":"Suzuki","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jvir.2024.07.010_bib16","first-page":"7042","article-title":"Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process","volume":"62","author":"Barbera-Guillem","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.jvir.2024.07.010_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/cmi.2014.83","article-title":"The origin and function of tumor-associated macrophages","volume":"12","author":"Liu","year":"2015","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jvir.2024.07.010_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jvir.2024.07.010_bib19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13045-017-0430-2","article-title":"Tumor-associated macrophages: from basic research to clinical application","volume":"10","author":"Yang","year":"2017","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.jvir.2024.07.010_bib20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.4287","article-title":"Towards the introduction of the \u2018Immunoscore\u2019 in the classification of malignant tumours","volume":"232","author":"Galon","year":"2014","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.jvir.2024.07.010_bib21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s40425-019-0814-7","article-title":"PD1(Hi) CD8(+) T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma","volume":"7","author":"Ma","year":"2019","journal-title":"J\u00a0Immunother Cancer"},{"key":"10.1016\/j.jvir.2024.07.010_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2022.100808","article-title":"The paradox of radiation and T cells in tumors","volume":"31","author":"Gough","year":"2022","journal-title":"Neoplasia"},{"key":"10.1016\/j.jvir.2024.07.010_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.653625","article-title":"The dynamic entropy of tumor immune infiltrates: the impact of recirculation, antigen-specific interactions, and retention on T cells in tumors","volume":"11","author":"Blair","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.jvir.2024.07.010_bib24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jvir.2013.10.030","article-title":"Pilot study of angiogenic response to yttrium-90 radioembolization with resin microspheres","volume":"25","author":"Carpizo","year":"2014","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2024.07.010_bib25","article-title":"PD-1 and TIGIT coexpression identifies a circulating CD8 T cell subset predictive of response to anti-PD-1 therapy","volume":"8","author":"Simon","year":"2020","journal-title":"J\u00a0Immunother Cancer"},{"key":"10.1016\/j.jvir.2024.07.010_bib26","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejca.2018.12.019","article-title":"Treatment sequencing in metastatic colorectal cancer","volume":"109","author":"Modest","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jvir.2024.07.010_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2019.101912","article-title":"Molecular insight of regorafenib treatment for colorectal cancer","volume":"81","author":"Arai","year":"2019","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jvir.2024.07.010_bib28","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvir.2024.07.010_bib29","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/s41590-020-0769-3","article-title":"The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies","volume":"21","author":"Kumagai","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jvir.2024.07.010_bib30","article-title":"Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy","volume":"9","author":"Pinato","year":"2021","journal-title":"J\u00a0Immunother Cancer"},{"key":"10.1016\/j.jvir.2024.07.010_bib31","author":"Rasband"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044324004664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044324004664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T09:09:02Z","timestamp":1732180142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044324004664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1051044324004664"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2024.07.010","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune Modulation in Untreated, Contralateral Hepatic Metastases after Yttrium-90 Radioembolization of Microsatellite Stable Colorectal Cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvir.2024.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 SIR 2024 .","name":"copyright","label":"Copyright"}]}}